Insider Transactions in Q4 2021 at Talaris Therapeutics, Inc. (TALS)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2021
|
Michael Zdanowski Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,470
+50.0%
|
$19,110
$13.0 P/Share
|
|
Dec 31
2021
|
Mary Kay Fenton Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+50.0%
|
$13,000
$13.0 P/Share
|
|
Dec 31
2021
|
Scott Requadt |
BUY
Grant, award, or other acquisition
|
Direct |
1,470
+0.32%
|
$19,110
$13.0 P/Share
|
|
Dec 15
2021
|
Francois Nader Director |
SELL
Bona fide gift
|
Indirect |
59,520
-15.04%
|
-
|
|
Nov 17
2021
|
Suzanne Ildstad Director |
BUY
Bona fide gift
|
Indirect |
1,200,000
+50.0%
|
-
|
|
Nov 17
2021
|
Suzanne Ildstad Director |
SELL
Bona fide gift
|
Direct |
1,200,000
-24.97%
|
-
|